As of 2025-12-20, the Intrinsic Value of XBiotech Inc (XBIT) is -4.88 USD. This XBIT valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.50 USD, the upside of XBiotech Inc is -295.28%.
Based on its market price of 2.50 USD and our intrinsic valuation, XBiotech Inc (XBIT) is overvalued by 295.28%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.88 - -4.88 | -4.88 | -295.28% |
| P/E | (12.42) - (17.26) | (17.28) | -791.3% |
| DDM - Stable | (7.45) - (21.94) | (14.70) | -687.8% |
| DDM - Multi | (9.03) - (20.89) | (12.63) | -605.3% |
| Market Cap (mil) | 76.22 |
| Beta | 1.36 |
| Outstanding shares (mil) | 30.49 |
| Enterprise Value (mil) | 76.22 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.59% |
| Cost of Debt | 5.00% |
| WACC | 9.92% |